Stonepine Capital Management LLC 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:35 pm Sale | 2023-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 669,684 3.900% | -184,358 (-21.59%) | Filing |
| 2023-02-13 10:58 am Sale | 2022-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 854,042 5.200% | -4,525 (-0.53%) | Filing |
| 2022-02-11 7:26 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 858,567 5.300% | 25,030 (+3.00%) | Filing |
| 2021-12-23 5:33 pm Purchase | 2021-12-20 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 833,537 5.200% | 833,537 (New Position) | Filing |